SP-23

N/A

Report date: 2024/04/01 14:31:12
NME

Base Information

Drug NameSP-23
Drug Alias NameSP-23
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionStimulator of interferon genes inhibitors
TargetsStimulator of interferon genes
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSouthern Medical University, China
China Registration ClassN/A

Develop Information

Active CompaniesSouthern Medical University, China
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A